Adial Pharmaceuticals Inc (ADIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 2,212 | 2,287 | 1,845 | 1,784 | 1,358 |
| Operating Income | -2,212 | -2,287 | -1,845 | -1,784 | -1,358 |
| Other Income | 20 | -171 | -4,632 | -121 | 10 |
| Pre-tax Income | -2,192 | -2,458 | -6,477 | -1,904 | -1,348 |
| Net Income Continuous | -2,192 | -2,458 | -6,477 | -1,904 | -1,348 |
| Net Income Discontinuous | N/A | N/A | N/A | -16 | -37 |
| Net Income | $-2,192 | $-2,458 | $-6,477 | $-1,920 | $-1,385 |
| EPS Basic Total Ops | -9.50 | -14.75 | -54.75 | -15.75 | -29.50 |
| EPS Basic Continuous Ops | -9.39 | -14.69 | -54.81 | -8.00 | -28.50 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -74.00 | -0.75 |
| EPS Diluted Total Ops | -9.50 | -14.75 | -54.75 | -15.75 | -29.50 |
| EPS Diluted Continuous Ops | -9.39 | -14.69 | -54.81 | -8.00 | -28.50 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -74.00 | -0.75 |
| EPS Diluted Before Non-Recurring Items | -9.50 | -14.75 | -17.00 | N/A | N/A |
| EBITDA(a) | $-2,211 | $-2,287 | $-1,845 | $-1,784 | $-1,358 |